002317.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:04):

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines...

Stats
Today's Volume	23.18M
Average Volume	32.16M
Market Cap	12.19B
EPS	CNY0.0823 ( 2023-10-30 )
Next earnings date	( CNY0 ) 2024-05-14
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	70.95
ATR14	CNY0.0160 (0.11%)

Volume Correlation

Long: 0.08 (neutral)

Short: 0.08 (neutral)

Signal:(55.259) Neutral

Guangdong Zhongsheng Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangdong Zhongsheng Correlation - Currency/Commodity

-0.18
( neutral )

-0.36
( neutral )

0.00
( neutral )

-0.18
( neutral )

-0.55
( weak negative )

Guangdong Zhongsheng Financials

Annual	2023
Revenue:	CNY2.61B
Gross Profit:	CNY1.53B (58.60 %)
EPS:	CNY0.320

FY	2023
Revenue:	CNY2.61B
Gross Profit:	CNY1.53B (58.60 %)
EPS:	CNY0.320

FY	2022
Revenue:	CNY2.68B
Gross Profit:	CNY1.74B (64.86 %)
EPS:	CNY0.400

FY	2021
Revenue:	CNY2.43B
Gross Profit:	CNY1.62B (66.80 %)
EPS:	CNY0.350

Financial Reports:

No articles found.

Guangdong Zhongsheng

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.